Three	B:C0450363
-	I:C0450363
dimensional	I:C0450363
carbon	O
nanotube	I:C1138408
scaffolds	O
for	O
long	O
-	O
term	O
maintenance	O
and	O
expansion	O
of	O
human	O
mesenchymal	O
stem	I:C1257975
cells	I:C1257975
.	O

Three	O
-	I:C0450363
dimensional	I:C0450363
carbon	B:C1138408
nanotube	I:C1138408
scaffolds	O
for	O
long	O
-	O
term	O
maintenance	O
and	O
expansion	O
of	O
human	O
mesenchymal	O
stem	I:C1257975
cells	I:C1257975
.	O

Three	O
-	I:C0450363
dimensional	I:C0450363
carbon	O
nanotube	I:C1138408
scaffolds	O
for	O
long	O
-	O
term	O
maintenance	O
and	O
expansion	O
of	O
human	B:C0086418
mesenchymal	O
stem	I:C1257975
cells	I:C1257975
.	O

Three	O
-	I:C0450363
dimensional	I:C0450363
carbon	O
nanotube	I:C1138408
scaffolds	O
for	O
long	O
-	O
term	O
maintenance	O
and	O
expansion	O
of	O
human	O
mesenchymal	B:C1257975
stem	I:C1257975
cells	I:C1257975
.	O

Expansion	O
of	O
mesenchymal	B:C1257975
stem	I:C1257975
cells	I:C1257975
(	O
mesenchymal	O
stem	I:C1257975
cells	I:C1257975
)	O
and	O
maintenance	O
of	O
their	O
self	O
-	I:C1155711
renewal	I:C1155711
capacity	O
in	O
vitro	O
requires	O
specialized	O
robust	O
cell	O
culture	I:C1516329
systems	I:C1516329
.	O

Expansion	O
of	O
mesenchymal	O
stem	I:C1257975
cells	I:C1257975
(	O
mesenchymal	B:C1257975
stem	I:C1257975
cells	I:C1257975
)	O
and	O
maintenance	O
of	O
their	O
self	O
-	I:C1155711
renewal	I:C1155711
capacity	O
in	O
vitro	O
requires	O
specialized	O
robust	O
cell	O
culture	I:C1516329
systems	I:C1516329
.	O

Expansion	O
of	O
mesenchymal	O
stem	I:C1257975
cells	I:C1257975
(	O
mesenchymal	O
stem	I:C1257975
cells	I:C1257975
)	O
and	O
maintenance	O
of	O
their	O
self	B:C1155711
-	I:C1155711
renewal	I:C1155711
capacity	O
in	O
vitro	O
requires	O
specialized	O
robust	O
cell	O
culture	I:C1516329
systems	I:C1516329
.	O

Expansion	O
of	O
mesenchymal	O
stem	I:C1257975
cells	I:C1257975
(	O
mesenchymal	O
stem	I:C1257975
cells	I:C1257975
)	O
and	O
maintenance	O
of	O
their	O
self	O
-	I:C1155711
renewal	I:C1155711
capacity	O
in	O
vitro	O
requires	O
specialized	O
robust	O
cell	B:C1516329
culture	I:C1516329
systems	I:C1516329
.	O

Conventional	O
approaches	O
using	O
animal	O
-	O
derived	O
or	O
artificial	O
matrices	O
and	O
a	O
cocktail	O
of	O
growth	B:C0018284
factors	I:C0018284
have	O
limitations	O
such	O
as	O
consistency	O
,	O
scalability	O
,	O
pathogenicity	O
,	O
and	O
loss	O
of	O
MSC	O
phenotype	O
.	O

Conventional	O
approaches	O
using	O
animal	O
-	O
derived	O
or	O
artificial	O
matrices	O
and	O
a	O
cocktail	O
of	O
growth	O
factors	I:C0018284
have	O
limitations	O
such	O
as	O
consistency	O
,	O
scalability	O
,	O
pathogenicity	O
,	O
and	O
loss	O
of	O
MSC	B:C1257975
phenotype	O
.	O

Herein	O
,	O
we	O
report	O
the	O
use	O
of	O
all	O
-	O
carbon	O
3	B:C0450363
-	I:C0450363
D	I:C0450363
single	O
-	O
and	O
multiwalled	O
carbon	I:C1138408
nanotube	I:C1138408
scaffolds	O
(	O
SWCNTs	O
and	O
MWCNTs	O
)	O
as	O
artificial	O
matrices	O
for	O
long	O
-	O
term	O
maintenance	O
and	O
expansion	O
of	O
human	O
mesenchymal	O
stem	I:C1257975
cells	I:C1257975
.	O

Herein	O
,	O
we	O
report	O
the	O
use	O
of	O
all	O
-	O
carbon	O
3	O
-	I:C0450363
D	I:C0450363
single	B:C1138408
-	O
and	O
multiwalled	O
carbon	I:C1138408
nanotube	I:C1138408
scaffolds	O
(	O
SWCNTs	O
and	O
MWCNTs	O
)	O
as	O
artificial	O
matrices	O
for	O
long	O
-	O
term	O
maintenance	O
and	O
expansion	O
of	O
human	O
mesenchymal	O
stem	I:C1257975
cells	I:C1257975
.	O

Herein	O
,	O
we	O
report	O
the	O
use	O
of	O
all	O
-	O
carbon	O
3	O
-	I:C0450363
D	I:C0450363
single	O
-	O
and	O
multiwalled	B:C1138408
carbon	I:C1138408
nanotube	I:C1138408
scaffolds	O
(	O
SWCNTs	O
and	O
MWCNTs	O
)	O
as	O
artificial	O
matrices	O
for	O
long	O
-	O
term	O
maintenance	O
and	O
expansion	O
of	O
human	O
mesenchymal	O
stem	I:C1257975
cells	I:C1257975
.	O

Herein	O
,	O
we	O
report	O
the	O
use	O
of	O
all	O
-	O
carbon	O
3	O
-	I:C0450363
D	I:C0450363
single	O
-	O
and	O
multiwalled	O
carbon	I:C1138408
nanotube	I:C1138408
scaffolds	O
(	O
SWCNTs	B:C1138408
and	O
MWCNTs	O
)	O
as	O
artificial	O
matrices	O
for	O
long	O
-	O
term	O
maintenance	O
and	O
expansion	O
of	O
human	O
mesenchymal	O
stem	I:C1257975
cells	I:C1257975
.	O

Herein	O
,	O
we	O
report	O
the	O
use	O
of	O
all	O
-	O
carbon	O
3	O
-	I:C0450363
D	I:C0450363
single	O
-	O
and	O
multiwalled	O
carbon	I:C1138408
nanotube	I:C1138408
scaffolds	O
(	O
SWCNTs	O
and	O
MWCNTs	B:C1138408
)	O
as	O
artificial	O
matrices	O
for	O
long	O
-	O
term	O
maintenance	O
and	O
expansion	O
of	O
human	O
mesenchymal	O
stem	I:C1257975
cells	I:C1257975
.	O

Herein	O
,	O
we	O
report	O
the	O
use	O
of	O
all	O
-	O
carbon	O
3	O
-	I:C0450363
D	I:C0450363
single	O
-	O
and	O
multiwalled	O
carbon	I:C1138408
nanotube	I:C1138408
scaffolds	O
(	O
SWCNTs	O
and	O
MWCNTs	O
)	O
as	O
artificial	O
matrices	O
for	O
long	O
-	O
term	O
maintenance	O
and	O
expansion	O
of	O
human	B:C0086418
mesenchymal	O
stem	I:C1257975
cells	I:C1257975
.	O

Herein	O
,	O
we	O
report	O
the	O
use	O
of	O
all	O
-	O
carbon	O
3	O
-	I:C0450363
D	I:C0450363
single	O
-	O
and	O
multiwalled	O
carbon	I:C1138408
nanotube	I:C1138408
scaffolds	O
(	O
SWCNTs	O
and	O
MWCNTs	O
)	O
as	O
artificial	O
matrices	O
for	O
long	O
-	O
term	O
maintenance	O
and	O
expansion	O
of	O
human	O
mesenchymal	B:C1257975
stem	I:C1257975
cells	I:C1257975
.	O

Three	B:C0450363
-	I:C0450363
dimensional	I:C0450363
SWCNT	O
and	O
MWCNT	O
scaffolds	O
were	O
fabricated	O
using	O
a	O
novel	O
radical	O
initiated	O
thermal	O
cross-linking	O
method	O
that	O
covalently	O
cross-links	O
CNTs	O
to	O
form	O
3	O
-	I:C0450363
D	I:C0450363
macroporous	O
all	O
-	O
carbon	O
architectures	O
.	O

Three	O
-	I:C0450363
dimensional	I:C0450363
SWCNT	B:C1138408
and	O
MWCNT	O
scaffolds	O
were	O
fabricated	O
using	O
a	O
novel	O
radical	O
initiated	O
thermal	O
cross-linking	O
method	O
that	O
covalently	O
cross-links	O
CNTs	O
to	O
form	O
3	O
-	I:C0450363
D	I:C0450363
macroporous	O
all	O
-	O
carbon	O
architectures	O
.	O

Three	O
-	I:C0450363
dimensional	I:C0450363
SWCNT	O
and	O
MWCNT	B:C1138408
scaffolds	O
were	O
fabricated	O
using	O
a	O
novel	O
radical	O
initiated	O
thermal	O
cross-linking	O
method	O
that	O
covalently	O
cross-links	O
CNTs	O
to	O
form	O
3	O
-	I:C0450363
D	I:C0450363
macroporous	O
all	O
-	O
carbon	O
architectures	O
.	O

Three	O
-	I:C0450363
dimensional	I:C0450363
SWCNT	O
and	O
MWCNT	O
scaffolds	O
were	O
fabricated	O
using	O
a	O
novel	O
radical	O
initiated	O
thermal	O
cross-linking	O
method	O
that	O
covalently	B:C1511539
cross-links	O
CNTs	O
to	O
form	O
3	O
-	I:C0450363
D	I:C0450363
macroporous	O
all	O
-	O
carbon	O
architectures	O
.	O

Three	O
-	I:C0450363
dimensional	I:C0450363
SWCNT	O
and	O
MWCNT	O
scaffolds	O
were	O
fabricated	O
using	O
a	O
novel	O
radical	O
initiated	O
thermal	O
cross-linking	O
method	O
that	O
covalently	O
cross-links	O
CNTs	B:C1138408
to	O
form	O
3	O
-	I:C0450363
D	I:C0450363
macroporous	O
all	O
-	O
carbon	O
architectures	O
.	O

Three	O
-	I:C0450363
dimensional	I:C0450363
SWCNT	O
and	O
MWCNT	O
scaffolds	O
were	O
fabricated	O
using	O
a	O
novel	O
radical	O
initiated	O
thermal	O
cross-linking	O
method	O
that	O
covalently	O
cross-links	O
CNTs	O
to	O
form	O
3	B:C0450363
-	I:C0450363
D	I:C0450363
macroporous	O
all	O
-	O
carbon	O
architectures	O
.	O

Three	O
-	I:C0450363
dimensional	I:C0450363
SWCNT	O
and	O
MWCNT	O
scaffolds	O
were	O
fabricated	O
using	O
a	O
novel	O
radical	O
initiated	O
thermal	O
cross-linking	O
method	O
that	O
covalently	O
cross-links	O
CNTs	O
to	O
form	O
3	O
-	I:C0450363
D	I:C0450363
macroporous	O
all	O
-	O
carbon	O
architectures	B:C1179586
.	O

Adipose	B:C1257975
-	I:C1257975
derived	I:C1257975
human	I:C1257975
MSCs	I:C1257975
showed	O
good	O
cell	O
viability	I:C0007620
,	O
attachment	O
,	O
proliferation	O
,	O
and	O
infiltration	O
in	O
MWCNT	O
and	O
SWCNT	O
scaffolds	O
comparable	O
to	O
poly	O
(	I:C0071599
lactic	I:C0071599
-	I:C0071599
co	I:C0071599
-	I:C0071599
glycolic	I:C0071599
)	I:C0071599
acid	I:C0071599
(	O
poly	O
(	I:C0071599
lactic	I:C0071599
-	I:C0071599
co	I:C0071599
-	I:C0071599
glycolic	I:C0071599
)	I:C0071599
acid	I:C0071599
)	O
scaffolds	O
(	O
baseline	O
control	O
)	O
.	O

Adipose	O
-	I:C1257975
derived	I:C1257975
human	I:C1257975
MSCs	I:C1257975
showed	O
good	O
cell	B:C0007620
viability	I:C0007620
,	O
attachment	O
,	O
proliferation	O
,	O
and	O
infiltration	O
in	O
MWCNT	O
and	O
SWCNT	O
scaffolds	O
comparable	O
to	O
poly	O
(	I:C0071599
lactic	I:C0071599
-	I:C0071599
co	I:C0071599
-	I:C0071599
glycolic	I:C0071599
)	I:C0071599
acid	I:C0071599
(	O
poly	O
(	I:C0071599
lactic	I:C0071599
-	I:C0071599
co	I:C0071599
-	I:C0071599
glycolic	I:C0071599
)	I:C0071599
acid	I:C0071599
)	O
scaffolds	O
(	O
baseline	O
control	O
)	O
.	O

Adipose	O
-	I:C1257975
derived	I:C1257975
human	I:C1257975
MSCs	I:C1257975
showed	O
good	O
cell	O
viability	I:C0007620
,	O
attachment	O
,	O
proliferation	O
,	O
and	O
infiltration	O
in	O
MWCNT	B:C1138408
and	O
SWCNT	O
scaffolds	O
comparable	O
to	O
poly	O
(	I:C0071599
lactic	I:C0071599
-	I:C0071599
co	I:C0071599
-	I:C0071599
glycolic	I:C0071599
)	I:C0071599
acid	I:C0071599
(	O
poly	O
(	I:C0071599
lactic	I:C0071599
-	I:C0071599
co	I:C0071599
-	I:C0071599
glycolic	I:C0071599
)	I:C0071599
acid	I:C0071599
)	O
scaffolds	O
(	O
baseline	O
control	O
)	O
.	O

Adipose	O
-	I:C1257975
derived	I:C1257975
human	I:C1257975
MSCs	I:C1257975
showed	O
good	O
cell	O
viability	I:C0007620
,	O
attachment	O
,	O
proliferation	O
,	O
and	O
infiltration	O
in	O
MWCNT	O
and	O
SWCNT	B:C1138408
scaffolds	O
comparable	O
to	O
poly	O
(	I:C0071599
lactic	I:C0071599
-	I:C0071599
co	I:C0071599
-	I:C0071599
glycolic	I:C0071599
)	I:C0071599
acid	I:C0071599
(	O
poly	O
(	I:C0071599
lactic	I:C0071599
-	I:C0071599
co	I:C0071599
-	I:C0071599
glycolic	I:C0071599
)	I:C0071599
acid	I:C0071599
)	O
scaffolds	O
(	O
baseline	O
control	O
)	O
.	O

Adipose	O
-	I:C1257975
derived	I:C1257975
human	I:C1257975
MSCs	I:C1257975
showed	O
good	O
cell	O
viability	I:C0007620
,	O
attachment	O
,	O
proliferation	O
,	O
and	O
infiltration	O
in	O
MWCNT	O
and	O
SWCNT	O
scaffolds	O
comparable	O
to	O
poly	B:C0071599
(	I:C0071599
lactic	I:C0071599
-	I:C0071599
co	I:C0071599
-	I:C0071599
glycolic	I:C0071599
)	I:C0071599
acid	I:C0071599
(	O
poly	O
(	I:C0071599
lactic	I:C0071599
-	I:C0071599
co	I:C0071599
-	I:C0071599
glycolic	I:C0071599
)	I:C0071599
acid	I:C0071599
)	O
scaffolds	O
(	O
baseline	O
control	O
)	O
.	O

Adipose	O
-	I:C1257975
derived	I:C1257975
human	I:C1257975
MSCs	I:C1257975
showed	O
good	O
cell	O
viability	I:C0007620
,	O
attachment	O
,	O
proliferation	O
,	O
and	O
infiltration	O
in	O
MWCNT	O
and	O
SWCNT	O
scaffolds	O
comparable	O
to	O
poly	O
(	I:C0071599
lactic	I:C0071599
-	I:C0071599
co	I:C0071599
-	I:C0071599
glycolic	I:C0071599
)	I:C0071599
acid	I:C0071599
(	O
poly	B:C0071599
(	I:C0071599
lactic	I:C0071599
-	I:C0071599
co	I:C0071599
-	I:C0071599
glycolic	I:C0071599
)	I:C0071599
acid	I:C0071599
)	O
scaffolds	O
(	O
baseline	O
control	O
)	O
.	O

ADSCs	B:C1257975
retained	O
stem	O
cell	I:C0038250
phenotype	O
after	O
30	O
days	O
and	O
satisfied	O
the	O
International	O
Society	I:C1561598
for	I:C1561598
Cellular	I:C1561598
Therapy	I:C1561598
's	I:C1561598
(	O
International	O
Society	I:C1561598
for	I:C1561598
Cellular	I:C1561598
Therapy	I:C1561598
's	I:C1561598
)	O
minimal	O
criteria	O
for	O
mesenchymal	O
stem	I:C1257975
cells	I:C1257975
.	O

ADSCs	O
retained	O
stem	B:C0038250
cell	I:C0038250
phenotype	O
after	O
30	O
days	O
and	O
satisfied	O
the	O
International	O
Society	I:C1561598
for	I:C1561598
Cellular	I:C1561598
Therapy	I:C1561598
's	I:C1561598
(	O
International	O
Society	I:C1561598
for	I:C1561598
Cellular	I:C1561598
Therapy	I:C1561598
's	I:C1561598
)	O
minimal	O
criteria	O
for	O
mesenchymal	O
stem	I:C1257975
cells	I:C1257975
.	O

ADSCs	O
retained	O
stem	O
cell	I:C0038250
phenotype	O
after	O
30	O
days	O
and	O
satisfied	O
the	O
International	B:C1561598
Society	I:C1561598
for	I:C1561598
Cellular	I:C1561598
Therapy	I:C1561598
's	I:C1561598
(	O
International	O
Society	I:C1561598
for	I:C1561598
Cellular	I:C1561598
Therapy	I:C1561598
's	I:C1561598
)	O
minimal	O
criteria	O
for	O
mesenchymal	O
stem	I:C1257975
cells	I:C1257975
.	O

ADSCs	O
retained	O
stem	O
cell	I:C0038250
phenotype	O
after	O
30	O
days	O
and	O
satisfied	O
the	O
International	O
Society	I:C1561598
for	I:C1561598
Cellular	I:C1561598
Therapy	I:C1561598
's	I:C1561598
(	O
International	B:C1561598
Society	I:C1561598
for	I:C1561598
Cellular	I:C1561598
Therapy	I:C1561598
's	I:C1561598
)	O
minimal	O
criteria	O
for	O
mesenchymal	O
stem	I:C1257975
cells	I:C1257975
.	O

ADSCs	O
retained	O
stem	O
cell	I:C0038250
phenotype	O
after	O
30	O
days	O
and	O
satisfied	O
the	O
International	O
Society	I:C1561598
for	I:C1561598
Cellular	I:C1561598
Therapy	I:C1561598
's	I:C1561598
(	O
International	O
Society	I:C1561598
for	I:C1561598
Cellular	I:C1561598
Therapy	I:C1561598
's	I:C1561598
)	O
minimal	O
criteria	O
for	O
mesenchymal	B:C1257975
stem	I:C1257975
cells	I:C1257975
.	O

Post	O
expansion	O
,	O
(	O
1	O
)	O
ADSCs	B:C1257975
showed	O
in	O
vitro	O
adherence	O
to	O
tissue	O
culture	I:C0032604
polystyrene	I:C0032604
(	O
tissue	O
culture	I:C0032604
polystyrene	I:C0032604
)	O
;	O
(	O
2	O
)	O
MSC	O
surface	O
antigen	I:C0003339
expression	O
[	O
CD14	O
(	O
-	O
)	O
,	O
CD19	O
(	O
-	O
)	O
,	O
CD34	O
(	O
-	O
)	O
,	O
CD45	O
(	O
-	O
)	O
,	O
CD73	O
(+	O
)	O
,	O
CD90	O
(+	O
)	O
,	O
CD105	O
(+	O
)	O
]	O
;	O
and	O
(	O
3	O
)	O
trilineage	O
differentiation	I:C0007589
into	O
osteoblasts	O
,	O
adipocytes	O
,	O
and	O
chondrocytes	O
.	O

Post	O
expansion	O
,	O
(	O
1	O
)	O
ADSCs	O
showed	O
in	O
vitro	O
adherence	O
to	O
tissue	B:C0032604
culture	I:C0032604
polystyrene	I:C0032604
(	O
tissue	O
culture	I:C0032604
polystyrene	I:C0032604
)	O
;	O
(	O
2	O
)	O
MSC	O
surface	O
antigen	I:C0003339
expression	O
[	O
CD14	O
(	O
-	O
)	O
,	O
CD19	O
(	O
-	O
)	O
,	O
CD34	O
(	O
-	O
)	O
,	O
CD45	O
(	O
-	O
)	O
,	O
CD73	O
(+	O
)	O
,	O
CD90	O
(+	O
)	O
,	O
CD105	O
(+	O
)	O
]	O
;	O
and	O
(	O
3	O
)	O
trilineage	O
differentiation	I:C0007589
into	O
osteoblasts	O
,	O
adipocytes	O
,	O
and	O
chondrocytes	O
.	O

Post	O
expansion	O
,	O
(	O
1	O
)	O
ADSCs	O
showed	O
in	O
vitro	O
adherence	O
to	O
tissue	O
culture	I:C0032604
polystyrene	I:C0032604
(	O
tissue	B:C0032604
culture	I:C0032604
polystyrene	I:C0032604
)	O
;	O
(	O
2	O
)	O
MSC	O
surface	O
antigen	I:C0003339
expression	O
[	O
CD14	O
(	O
-	O
)	O
,	O
CD19	O
(	O
-	O
)	O
,	O
CD34	O
(	O
-	O
)	O
,	O
CD45	O
(	O
-	O
)	O
,	O
CD73	O
(+	O
)	O
,	O
CD90	O
(+	O
)	O
,	O
CD105	O
(+	O
)	O
]	O
;	O
and	O
(	O
3	O
)	O
trilineage	O
differentiation	I:C0007589
into	O
osteoblasts	O
,	O
adipocytes	O
,	O
and	O
chondrocytes	O
.	O

Post	O
expansion	O
,	O
(	O
1	O
)	O
ADSCs	O
showed	O
in	O
vitro	O
adherence	O
to	O
tissue	O
culture	I:C0032604
polystyrene	I:C0032604
(	O
tissue	O
culture	I:C0032604
polystyrene	I:C0032604
)	O
;	O
(	O
2	O
)	O
MSC	B:C1257975
surface	O
antigen	I:C0003339
expression	O
[	O
CD14	O
(	O
-	O
)	O
,	O
CD19	O
(	O
-	O
)	O
,	O
CD34	O
(	O
-	O
)	O
,	O
CD45	O
(	O
-	O
)	O
,	O
CD73	O
(+	O
)	O
,	O
CD90	O
(+	O
)	O
,	O
CD105	O
(+	O
)	O
]	O
;	O
and	O
(	O
3	O
)	O
trilineage	O
differentiation	I:C0007589
into	O
osteoblasts	O
,	O
adipocytes	O
,	O
and	O
chondrocytes	O
.	O

Post	O
expansion	O
,	O
(	O
1	O
)	O
ADSCs	O
showed	O
in	O
vitro	O
adherence	O
to	O
tissue	O
culture	I:C0032604
polystyrene	I:C0032604
(	O
tissue	O
culture	I:C0032604
polystyrene	I:C0032604
)	O
;	O
(	O
2	O
)	O
MSC	O
surface	B:C0003339
antigen	I:C0003339
expression	O
[	O
CD14	O
(	O
-	O
)	O
,	O
CD19	O
(	O
-	O
)	O
,	O
CD34	O
(	O
-	O
)	O
,	O
CD45	O
(	O
-	O
)	O
,	O
CD73	O
(+	O
)	O
,	O
CD90	O
(+	O
)	O
,	O
CD105	O
(+	O
)	O
]	O
;	O
and	O
(	O
3	O
)	O
trilineage	O
differentiation	I:C0007589
into	O
osteoblasts	O
,	O
adipocytes	O
,	O
and	O
chondrocytes	O
.	O

Post	O
expansion	O
,	O
(	O
1	O
)	O
ADSCs	O
showed	O
in	O
vitro	O
adherence	O
to	O
tissue	O
culture	I:C0032604
polystyrene	I:C0032604
(	O
tissue	O
culture	I:C0032604
polystyrene	I:C0032604
)	O
;	O
(	O
2	O
)	O
MSC	O
surface	O
antigen	I:C0003339
expression	B:C1171362
[	O
CD14	O
(	O
-	O
)	O
,	O
CD19	O
(	O
-	O
)	O
,	O
CD34	O
(	O
-	O
)	O
,	O
CD45	O
(	O
-	O
)	O
,	O
CD73	O
(+	O
)	O
,	O
CD90	O
(+	O
)	O
,	O
CD105	O
(+	O
)	O
]	O
;	O
and	O
(	O
3	O
)	O
trilineage	O
differentiation	I:C0007589
into	O
osteoblasts	O
,	O
adipocytes	O
,	O
and	O
chondrocytes	O
.	O

Post	O
expansion	O
,	O
(	O
1	O
)	O
ADSCs	O
showed	O
in	O
vitro	O
adherence	O
to	O
tissue	O
culture	I:C0032604
polystyrene	I:C0032604
(	O
tissue	O
culture	I:C0032604
polystyrene	I:C0032604
)	O
;	O
(	O
2	O
)	O
MSC	O
surface	O
antigen	I:C0003339
expression	O
[	O
CD14	B:C0108768
(	O
-	O
)	O
,	O
CD19	O
(	O
-	O
)	O
,	O
CD34	O
(	O
-	O
)	O
,	O
CD45	O
(	O
-	O
)	O
,	O
CD73	O
(+	O
)	O
,	O
CD90	O
(+	O
)	O
,	O
CD105	O
(+	O
)	O
]	O
;	O
and	O
(	O
3	O
)	O
trilineage	O
differentiation	I:C0007589
into	O
osteoblasts	O
,	O
adipocytes	O
,	O
and	O
chondrocytes	O
.	O

Post	O
expansion	O
,	O
(	O
1	O
)	O
ADSCs	O
showed	O
in	O
vitro	O
adherence	O
to	O
tissue	O
culture	I:C0032604
polystyrene	I:C0032604
(	O
tissue	O
culture	I:C0032604
polystyrene	I:C0032604
)	O
;	O
(	O
2	O
)	O
MSC	O
surface	O
antigen	I:C0003339
expression	O
[	O
CD14	O
(	O
-	O
)	O
,	O
CD19	B:C0108748
(	O
-	O
)	O
,	O
CD34	O
(	O
-	O
)	O
,	O
CD45	O
(	O
-	O
)	O
,	O
CD73	O
(+	O
)	O
,	O
CD90	O
(+	O
)	O
,	O
CD105	O
(+	O
)	O
]	O
;	O
and	O
(	O
3	O
)	O
trilineage	O
differentiation	I:C0007589
into	O
osteoblasts	O
,	O
adipocytes	O
,	O
and	O
chondrocytes	O
.	O

Post	O
expansion	O
,	O
(	O
1	O
)	O
ADSCs	O
showed	O
in	O
vitro	O
adherence	O
to	O
tissue	O
culture	I:C0032604
polystyrene	I:C0032604
(	O
tissue	O
culture	I:C0032604
polystyrene	I:C0032604
)	O
;	O
(	O
2	O
)	O
MSC	O
surface	O
antigen	I:C0003339
expression	O
[	O
CD14	O
(	O
-	O
)	O
,	O
CD19	O
(	O
-	O
)	O
,	O
CD34	B:C0054953
(	O
-	O
)	O
,	O
CD45	O
(	O
-	O
)	O
,	O
CD73	O
(+	O
)	O
,	O
CD90	O
(+	O
)	O
,	O
CD105	O
(+	O
)	O
]	O
;	O
and	O
(	O
3	O
)	O
trilineage	O
differentiation	I:C0007589
into	O
osteoblasts	O
,	O
adipocytes	O
,	O
and	O
chondrocytes	O
.	O

Post	O
expansion	O
,	O
(	O
1	O
)	O
ADSCs	O
showed	O
in	O
vitro	O
adherence	O
to	O
tissue	O
culture	I:C0032604
polystyrene	I:C0032604
(	O
tissue	O
culture	I:C0032604
polystyrene	I:C0032604
)	O
;	O
(	O
2	O
)	O
MSC	O
surface	O
antigen	I:C0003339
expression	O
[	O
CD14	O
(	O
-	O
)	O
,	O
CD19	O
(	O
-	O
)	O
,	O
CD34	O
(	O
-	O
)	O
,	O
CD45	B:C0054961
(	O
-	O
)	O
,	O
CD73	O
(+	O
)	O
,	O
CD90	O
(+	O
)	O
,	O
CD105	O
(+	O
)	O
]	O
;	O
and	O
(	O
3	O
)	O
trilineage	O
differentiation	I:C0007589
into	O
osteoblasts	O
,	O
adipocytes	O
,	O
and	O
chondrocytes	O
.	O

Post	O
expansion	O
,	O
(	O
1	O
)	O
ADSCs	O
showed	O
in	O
vitro	O
adherence	O
to	O
tissue	O
culture	I:C0032604
polystyrene	I:C0032604
(	O
tissue	O
culture	I:C0032604
polystyrene	I:C0032604
)	O
;	O
(	O
2	O
)	O
MSC	O
surface	O
antigen	I:C0003339
expression	O
[	O
CD14	O
(	O
-	O
)	O
,	O
CD19	O
(	O
-	O
)	O
,	O
CD34	O
(	O
-	O
)	O
,	O
CD45	O
(	O
-	O
)	O
,	O
CD73	B:C0000530
(+	O
)	O
,	O
CD90	O
(+	O
)	O
,	O
CD105	O
(+	O
)	O
]	O
;	O
and	O
(	O
3	O
)	O
trilineage	O
differentiation	I:C0007589
into	O
osteoblasts	O
,	O
adipocytes	O
,	O
and	O
chondrocytes	O
.	O

Post	O
expansion	O
,	O
(	O
1	O
)	O
ADSCs	O
showed	O
in	O
vitro	O
adherence	O
to	O
tissue	O
culture	I:C0032604
polystyrene	I:C0032604
(	O
tissue	O
culture	I:C0032604
polystyrene	I:C0032604
)	O
;	O
(	O
2	O
)	O
MSC	O
surface	O
antigen	I:C0003339
expression	O
[	O
CD14	O
(	O
-	O
)	O
,	O
CD19	O
(	O
-	O
)	O
,	O
CD34	O
(	O
-	O
)	O
,	O
CD45	O
(	O
-	O
)	O
,	O
CD73	O
(+	O
)	O
,	O
CD90	B:C0076570
(+	O
)	O
,	O
CD105	O
(+	O
)	O
]	O
;	O
and	O
(	O
3	O
)	O
trilineage	O
differentiation	I:C0007589
into	O
osteoblasts	O
,	O
adipocytes	O
,	O
and	O
chondrocytes	O
.	O

Post	O
expansion	O
,	O
(	O
1	O
)	O
ADSCs	O
showed	O
in	O
vitro	O
adherence	O
to	O
tissue	O
culture	I:C0032604
polystyrene	I:C0032604
(	O
tissue	O
culture	I:C0032604
polystyrene	I:C0032604
)	O
;	O
(	O
2	O
)	O
MSC	O
surface	O
antigen	I:C0003339
expression	O
[	O
CD14	O
(	O
-	O
)	O
,	O
CD19	O
(	O
-	O
)	O
,	O
CD34	O
(	O
-	O
)	O
,	O
CD45	O
(	O
-	O
)	O
,	O
CD73	O
(+	O
)	O
,	O
CD90	O
(+	O
)	O
,	O
CD105	B:C0082420
(+	O
)	O
]	O
;	O
and	O
(	O
3	O
)	O
trilineage	O
differentiation	I:C0007589
into	O
osteoblasts	O
,	O
adipocytes	O
,	O
and	O
chondrocytes	O
.	O

Post	O
expansion	O
,	O
(	O
1	O
)	O
ADSCs	O
showed	O
in	O
vitro	O
adherence	O
to	O
tissue	O
culture	I:C0032604
polystyrene	I:C0032604
(	O
tissue	O
culture	I:C0032604
polystyrene	I:C0032604
)	O
;	O
(	O
2	O
)	O
MSC	O
surface	O
antigen	I:C0003339
expression	O
[	O
CD14	O
(	O
-	O
)	O
,	O
CD19	O
(	O
-	O
)	O
,	O
CD34	O
(	O
-	O
)	O
,	O
CD45	O
(	O
-	O
)	O
,	O
CD73	O
(+	O
)	O
,	O
CD90	O
(+	O
)	O
,	O
CD105	O
(+	O
)	O
]	O
;	O
and	O
(	O
3	O
)	O
trilineage	B:C0007589
differentiation	I:C0007589
into	O
osteoblasts	O
,	O
adipocytes	O
,	O
and	O
chondrocytes	O
.	O

Post	O
expansion	O
,	O
(	O
1	O
)	O
ADSCs	O
showed	O
in	O
vitro	O
adherence	O
to	O
tissue	O
culture	I:C0032604
polystyrene	I:C0032604
(	O
tissue	O
culture	I:C0032604
polystyrene	I:C0032604
)	O
;	O
(	O
2	O
)	O
MSC	O
surface	O
antigen	I:C0003339
expression	O
[	O
CD14	O
(	O
-	O
)	O
,	O
CD19	O
(	O
-	O
)	O
,	O
CD34	O
(	O
-	O
)	O
,	O
CD45	O
(	O
-	O
)	O
,	O
CD73	O
(+	O
)	O
,	O
CD90	O
(+	O
)	O
,	O
CD105	O
(+	O
)	O
]	O
;	O
and	O
(	O
3	O
)	O
trilineage	O
differentiation	I:C0007589
into	O
osteoblasts	B:C0029418
,	O
adipocytes	O
,	O
and	O
chondrocytes	O
.	O

Post	O
expansion	O
,	O
(	O
1	O
)	O
ADSCs	O
showed	O
in	O
vitro	O
adherence	O
to	O
tissue	O
culture	I:C0032604
polystyrene	I:C0032604
(	O
tissue	O
culture	I:C0032604
polystyrene	I:C0032604
)	O
;	O
(	O
2	O
)	O
MSC	O
surface	O
antigen	I:C0003339
expression	O
[	O
CD14	O
(	O
-	O
)	O
,	O
CD19	O
(	O
-	O
)	O
,	O
CD34	O
(	O
-	O
)	O
,	O
CD45	O
(	O
-	O
)	O
,	O
CD73	O
(+	O
)	O
,	O
CD90	O
(+	O
)	O
,	O
CD105	O
(+	O
)	O
]	O
;	O
and	O
(	O
3	O
)	O
trilineage	O
differentiation	I:C0007589
into	O
osteoblasts	O
,	O
adipocytes	B:C0206131
,	O
and	O
chondrocytes	O
.	O

Post	O
expansion	O
,	O
(	O
1	O
)	O
ADSCs	O
showed	O
in	O
vitro	O
adherence	O
to	O
tissue	O
culture	I:C0032604
polystyrene	I:C0032604
(	O
tissue	O
culture	I:C0032604
polystyrene	I:C0032604
)	O
;	O
(	O
2	O
)	O
MSC	O
surface	O
antigen	I:C0003339
expression	O
[	O
CD14	O
(	O
-	O
)	O
,	O
CD19	O
(	O
-	O
)	O
,	O
CD34	O
(	O
-	O
)	O
,	O
CD45	O
(	O
-	O
)	O
,	O
CD73	O
(+	O
)	O
,	O
CD90	O
(+	O
)	O
,	O
CD105	O
(+	O
)	O
]	O
;	O
and	O
(	O
3	O
)	O
trilineage	O
differentiation	I:C0007589
into	O
osteoblasts	O
,	O
adipocytes	O
,	O
and	O
chondrocytes	B:C0225369
.	O

Results	O
show	O
that	O
cross	O
-	O
linked	O
3	B:C0450363
-	I:C0450363
D	I:C0450363
MWCNTs	O
and	O
SWCNTs	O
scaffolds	O
are	O
suitable	O
for	O
ex	O
vivo	O
expansion	O
and	O
maintenance	O
of	O
mesenchymal	O
stem	I:C1257975
cells	I:C1257975
for	O
therapeutic	O
applications	O
.	O

Results	O
show	O
that	O
cross	O
-	O
linked	O
3	O
-	I:C0450363
D	I:C0450363
MWCNTs	B:C1138408
and	O
SWCNTs	O
scaffolds	O
are	O
suitable	O
for	O
ex	O
vivo	O
expansion	O
and	O
maintenance	O
of	O
mesenchymal	O
stem	I:C1257975
cells	I:C1257975
for	O
therapeutic	O
applications	O
.	O

Results	O
show	O
that	O
cross	O
-	O
linked	O
3	O
-	I:C0450363
D	I:C0450363
MWCNTs	O
and	O
SWCNTs	B:C1138408
scaffolds	O
are	O
suitable	O
for	O
ex	O
vivo	O
expansion	O
and	O
maintenance	O
of	O
mesenchymal	O
stem	I:C1257975
cells	I:C1257975
for	O
therapeutic	O
applications	O
.	O

Results	O
show	O
that	O
cross	O
-	O
linked	O
3	O
-	I:C0450363
D	I:C0450363
MWCNTs	O
and	O
SWCNTs	O
scaffolds	O
are	O
suitable	O
for	O
ex	O
vivo	O
expansion	O
and	O
maintenance	O
of	O
mesenchymal	B:C1257975
stem	I:C1257975
cells	I:C1257975
for	O
therapeutic	O
applications	O
.	O

Results	O
show	O
that	O
cross	O
-	O
linked	O
3	O
-	I:C0450363
D	I:C0450363
MWCNTs	O
and	O
SWCNTs	O
scaffolds	O
are	O
suitable	O
for	O
ex	O
vivo	O
expansion	O
and	O
maintenance	O
of	O
mesenchymal	O
stem	I:C1257975
cells	I:C1257975
for	O
therapeutic	B:C0087111
applications	O
.	O

